BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37537343)

  • 21. Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression.
    Fang E; Wang X; Wang J; Hu A; Song H; Yang F; Li D; Xiao W; Chen Y; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
    Theranostics; 2020; 10(4):1555-1571. PubMed ID: 32042322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA NR2F1-AS1 promoted neuroblastoma progression through miR-493-5p/TRIM2 axis.
    Liu L; Zhao H; He HH; Huang J; Xu YY; Li XL; Wu Y; Wang J; Zhu YB
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12748-12756. PubMed ID: 33378023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR.
    Wang C; Liu Z; Woo CW; Li Z; Wang L; Wei JS; Marquez VE; Bates SE; Jin Q; Khan J; Ge K; Thiele CJ
    Cancer Res; 2012 Jan; 72(1):315-24. PubMed ID: 22068036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
    Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.
    Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z
    J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NR1D1-transactivated lncRNA NUTM2A-AS1 promotes chemoresistance and immune evasion in neuroblastoma via inhibiting B7-H3 degradation.
    Xiang T; Li Y; Liu G; Li X
    J Cell Mol Med; 2024 May; 28(10):e18360. PubMed ID: 38785199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.
    Lv J; Qiu M; Xia W; Liu C; Xu Y; Wang J; Leng X; Huang S; Zhu R; Zhao M; Ji F; Xu L; Xu K; Yin R
    J Exp Clin Cancer Res; 2016 May; 35():75. PubMed ID: 27154193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA GATA2-AS1 augments endothelial hypoxia inducible factor 1-α induction and regulates hypoxic signaling.
    Man HSJ; Subramaniam N; Downs T; Sukumar AN; Saha AD; Nair R; Chen L; Teitelbaum D; Turgeon PJ; Ku KH; Tran E; de Perrot M; Marsden PA
    J Biol Chem; 2023 May; 299(5):103029. PubMed ID: 36806681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic Targeting of
    Fang E; Wang X; Yang F; Hu A; Wang J; Li D; Song H; Hong M; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
    Adv Sci (Weinh); 2019 Oct; 6(19):1900581. PubMed ID: 31592410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.
    Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W
    Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long noncoding RNA LINC00200 promotes the malignant progression of MYCN-amplified neuroblastoma via binding to insulin like growth factor 2 mRNA binding protein 3 (IGF2BP3) to enhance the stability of Zic family member 2 (ZIC2) mRNA.
    Chen J; Sun M; Huang L; Fang Y
    Pathol Res Pract; 2022 Sep; 237():154059. PubMed ID: 35969939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
    Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
    Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DGCR8/ZFAT-AS1 Promotes CDX2 Transcription in a PRC2 Complex-Dependent Manner to Facilitate the Malignant Biological Behavior of Glioma Cells.
    Zhang F; Ruan X; Ma J; Liu X; Zheng J; Liu Y; Liu L; Shen S; Shao L; Wang D; Yang C; Cai H; Li Z; Feng Z; Xue Y
    Mol Ther; 2020 Feb; 28(2):613-630. PubMed ID: 31813799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
    Shen Y; Lv M; Fang Y; Lu J; Wu Y
    J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF.
    Kong F; Deng X; Kong X; Du Y; Li L; Zhu H; Wang Y; Xie D; Guha S; Li Z; Guan M; Xie K
    Oncogene; 2018 Nov; 37(45):5982-5996. PubMed ID: 29985481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The malate-aspartate shuttle (Borst cycle): How it started and developed into a major metabolic pathway.
    Borst P
    IUBMB Life; 2020 Nov; 72(11):2241-2259. PubMed ID: 32916028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
    Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
    Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
    Zheng L; Chen J; Zhou Z; He Z
    Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition.
    Yao J; Xu F; Zhang D; Yi W; Chen X; Chen G; Zhou E
    J Cell Biochem; 2018 Jan; 119(1):680-690. PubMed ID: 28639399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
    Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y
    Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.